Cargando…

PReS-FINAL-2326: No correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of Anakinra (Kineret(®)) in patients with severe CAPS

Detalles Bibliográficos
Autores principales:	Wikén, M, Gozzi, P, Andersson, G, Olivecrona, H, Aldén Raboisson, M, Kullenberg, T, Leinonen, M, Hallén, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044047/ http://dx.doi.org/10.1186/1546-0096-11-S2-P316

Ejemplares similares

PW02-039 - Long-term anakinra treatment in CAPS: a metaanalys
por: Leinonen, M, et al.
Publicado: (2013)

The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)
por: Leinonen, Mika, et al.
Publicado: (2014)

Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations
por: Kaiser, Christina, et al.
Publicado: (2011)

Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes
por: Kullenberg, Torbjörn, et al.
Publicado: (2016)

Anakinra (Kineret) in psoriasis and psoriatic arthritis: a single-center, open-label, pilot study
por: Gibbs, A, et al.
Publicado: (2005)

PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret(®)) in systemic juvenile idiopathic arthritis
por: Livermore, P, et al.
Publicado: (2008)

Pharmacokinetics of Anakinra in Subjects of Heavier vs. Lighter Body Weights
por: Yang, Bing‐Bing, et al.
Publicado: (2019)

PReS-FINAL-2178: Clinical and microarray follow-up of SJIA patients treated with anakinra over the past 10 years in a single institution
por: Punaro, M, et al.
Publicado: (2013)

PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

2326: Successful hand function recovery after stroke
por: Geed, Shashwati, et al.
Publicado: (2018)

PReS-FINAL-1010: circulating micrornas in traps
por: Lucherini, OM, et al.
Publicado: (2013)

PReS-FINAL-2240: Serum amyloid protein a concentration in CAPS patients treated with anti IL1Β
por: Pastore, S, et al.
Publicado: (2013)

PReS-FINAL-2199: A novel mutation in the CIAS1/NLRP3 gene associated with an unusual phenotype of CAPS
por: Insalaco, A, et al.
Publicado: (2013)

PReS-FINAL-2241: Cases of cryopyrin-associated periodic syndromes (CAPS) in one single rheumatologic center of Russia
por: Salugina, SO, et al.
Publicado: (2013)

2326. Necessity of Anaerobic Blood Cultures for Identification of Pediatric Bloodstream Infections
por: Mitchell, Kaitlin, et al.
Publicado: (2018)

PReS-FINAL-2220: Cochlear involvement in FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS-FINAL-2221: An earliest diagnosis of FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

Effect of the IL-1 Receptor Antagonist Kineret(®) on Disease Phenotype in mdx Mice
por: Benny Klimek, Margaret E., et al.
Publicado: (2016)

PReS-FINAL-2210: Qualitative aspects of autoinflammatory diseases
por: Konukbay, D, et al.
Publicado: (2013)

PReS-FINAL-2175: Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring
por: Woillard, JB, et al.
Publicado: (2013)

PReS-FINAL-2006: Resilience and coping in adolentes with rheumatic illness
por: Alessio, M, et al.
Publicado: (2013)

PReS-FINAL-2329: Validation of the autoinflammatory activity index (AIDAI)
por: Piram, M, et al.
Publicado: (2013)

PReS-FINAL-2254: Is it systemic JIA or post infectious illness?
por: Guddeti, P, et al.
Publicado: (2013)

Anakinra in children and adults with Still’s disease
por: Vastert, Sebastiaan J, et al.
Publicado: (2019)

PReS-FINAL-2217: Atypical presentation of CRMO in two children
por: Vanoni, F, et al.
Publicado: (2013)

PReS-FINAL-2025: Arthritis associated with human immunodeficiency virus
por: Bean, AE, et al.
Publicado: (2013)

PReS-FINAL-2227: QT and JT dispersion in children with FMF
por: Fidanci, K, et al.
Publicado: (2013)

PReS-FINAL-2361: Maintenance treatment in childhood granulomatosis with polyangiitis
por: Twilt, M, et al.
Publicado: (2013)

PReS-FINAL-2277: Clubbing fingers in a boy with arthritis
por: Giani, T, et al.
Publicado: (2013)

PReS-FINAL-2259: Spectrum of Sjögren syndrome in children
por: Bica, BE, et al.
Publicado: (2013)

PReS-FINAL-2087: Diagnosis of arthritis: history or laboratory?
por: Yurtsever, O, et al.
Publicado: (2013)

PReS-FINAL-2219: Evaluation of autonomic function in FMF
por: Aktay Ayaz, N, et al.
Publicado: (2013)

PReS-FINAL-2222: FMF presenting with the features of malignancy
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS-FINAL-2124: Electromyography assessment in localized scleroderma
por: Fernandes, TP, et al.
Publicado: (2013)

PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
por: Bellutti Enders, F, et al.
Publicado: (2013)

PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
por: Moretti, D, et al.
Publicado: (2013)

PReS-FINAL-2366: Paediatric rheumatology in South Africa
por: Scott, C
Publicado: (2013)

PReS-FINAL-2330: Canakinumab treatment in patients with HIDS
por: Antón, J, et al.
Publicado: (2013)

PReS-FINAL-2127: Sclerodermatous graft versus host disease
por: Stevenson, JR, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qnea8grn5paru5huss6omnu0m8